Pure Global

Clinical Evaluation of the Safety and Efficacy of Yung Sheng 55 % Color Contact Lens - Trial NCT06128486

Access comprehensive clinical trial information for NCT06128486 through Pure Global AI's free database. This phase not specified trial is sponsored by Yung Sheng Optical Co., Ltd. and is currently Completed. The study focuses on Myopia. Target enrollment is 62 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
Device Trial
NCT06128486
Completed
Device Trial
device
Trial Details
ClinicalTrials.gov โ€ข NCT06128486
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Clinical Evaluation of the Safety and Efficacy of Yung Sheng 55 % Color Contact Lens

Study Focus

Myopia

Soft Contact Lens

Interventional

device

Sponsor & Location

Yung Sheng Optical Co., Ltd.

Timeline & Enrollment

N/A

Aug 25, 2012

Mar 17, 2014

62 participants

Primary Outcome

The effectiveness of corrected visual acuity

Summary

This was a single group, open-label clinical study to assess the safety and efficacy of Yung
 Sheng 55% Color Contact Lens for vision correction.

ICD-10 Classifications

Myopia
Degenerative myopia
Amblyopia ex anopsia
Ocular myiasis
Myiasis

Data Source

ClinicalTrials.gov

NCT06128486

Device Trial